Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021
Open issues in the transition from nafld to mafld. the experience of the plinio study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH	2021
The challenge of cardiovascular prevention in NAFLD	THE LANCET. GASTROENTEROLOGY & HEPATOLOGY	2021
Antiphospholipid antibodies and heart failure with preserved ejection fraction. The multicenter ATHERO-APS study	JOURNAL OF CLINICAL MEDICINE	2021
D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients. asystematic review and metanalysis	THROMBOSIS JOURNAL	2021
Oxidative stress in the pathogenesis of antiphospholipid syndrome. Implications for the atherothrombotic process	ANTIOXIDANTS	2021
A systematic review and a meta-analysis comparing prophylactic and therapeutic low molecular weight heparins for mortality reduction in 32,688 COVID-19 patients	FRONTIERS IN PHARMACOLOGY	2021
Use of direct oral anticoagulants in patients with antiphospholipid syndrome. a systematic review and comparison of the international guidelines	FRONTIERS IN CARDIOVASCULAR MEDICINE	2021
Circulating lipopolysaccharides and impaired antioxidant status in patients with atrial fibrillation. data from the athero-af study	FRONTIERS IN CARDIOVASCULAR MEDICINE	2021
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure. randomized trials and beyond	HEART FAILURE REVIEWS	2021
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes. insights from the START-ANTIPLATELET registry	INTERNATIONAL JOURNAL OF CARDIOLOGY	2021
Thrombosis in pre- and post-vaccination phase of COVID-19	EUROPEAN HEART JOURNAL SUPPLEMENTS	2021
Commentary on "Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial"	HEPATOBILIARY SURGERY AND NUTRITION	2021
Serum albumin, clotting activation and COVID-19 severity: a systematic review and meta-regression analysis of 4579 patients	ITALIAN JOURNAL OF EMERGENCY MEDICINE	2021
Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY	2020
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. the nationwide PLECTRUM study	BRITISH JOURNAL OF HAEMATOLOGY	2020
Upper extremity deep vein thrombosis treated with direct oral anticoagulants. a multi-center real world experience	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2020
Seronegative antiphospholipid syndrome: Refining the value of “non-criteria” antibodies for diagnosis and clinical management	HAEMATOLOGICA	2020
A novel role of MMP2 in regulating platelet NOX2 activation	FREE RADICAL BIOLOGY & MEDICINE	2020
PCSK9 regulates Nox2-mediated platelet activation via CD36 receptor in patients with atrial fibrillation	ANTIOXIDANTS	2020

« prima
< precedente
…
2
3
4
5
6
7
8
9
10
11
12
13
…
seguente ›
ultima »

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.